As schools are expected to open their doors soon, Britain’s health regulator extended its approval for the Moderna COVID-19 vaccine to children aged 12 to 17 years, a few weeks after the Pfizer jab was approved for the same age group.
June Raine, the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) stated: “The vaccine is safe and effective in this age group. We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines and this surveillance will include the 12- to 17-year age group.”
The approval is granted for use in England, Scotland and wales. The MHRA proclaimed the Moderna vaccine, also called Spikevax, as “safe and effective in this age group.” It has already been authorized for use in children aged 12 – 17 years old in Northern Ireland.
Green lights were also given on August 4 by Britain’s Joint Committee on Vaccination and Immunisation (JCVI) for 16 and 17-years-olds to receive their first dose of Pfizer’s vaccine.
In the present time, 12 to 15-year-olds are able to get jabbed by the Pfizer-BioNTech vaccine in Britain if considered clinically vulnerable or live with someone at risk.
The National Education Union, which represents teachers and education professionals, uttered vaccinations of 16 and 17-year-olds would aid to reduce disruption to education in the next academic year, however, additional safety measures need to be respected in order for schools to continue.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.